BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 21539341)

  • 1. Insights into the interaction of discodermolide and docetaxel with tubulin. Mapping the binding sites of microtubule-stabilizing agents by using an integrated NMR and computational approach.
    Canales A; Rodríguez-Salarichs J; Trigili C; Nieto L; Coderch C; Andreu JM; Paterson I; Jiménez-Barbero J; Díaz JF
    ACS Chem Biol; 2011 Aug; 6(8):789-99. PubMed ID: 21539341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A photoaffinity analogue of discodermolide specifically labels a peptide in beta-tubulin.
    Xia S; Kenesky CS; Rucker PV; Smith AB; Orr GA; Horwitz SB
    Biochemistry; 2006 Oct; 45(39):11762-75. PubMed ID: 17002277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct pose of discodermolide in taxol binding pocket drives a complementary mode of microtubule stabilization.
    Khrapunovich-Baine M; Menon V; Verdier-Pinard P; Smith AB; Angeletti RH; Fiser A; Horwitz SB; Xiao H
    Biochemistry; 2009 Dec; 48(49):11664-77. PubMed ID: 19863156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tubulin assembly, taxoid site binding, and cellular effects of the microtubule-stabilizing agent dictyostatin.
    Madiraju C; Edler MC; Hamel E; Raccor BS; Balachandran R; Zhu G; Giuliano KA; Vogt A; Shin Y; Fournier JH; Fukui Y; Brückner AM; Curran DP; Day BW
    Biochemistry; 2005 Nov; 44(45):15053-63. PubMed ID: 16274252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bound conformation of microtubule-stabilizing agents: NMR insights into the bioactive 3D structure of discodermolide and dictyostatin.
    Canales A; Matesanz R; Gardner NM; Andreu JM; Paterson I; Díaz JF; Jiménez-Barbero J
    Chemistry; 2008; 14(25):7557-69. PubMed ID: 18449868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of natural product microtubule stabilizers on microtubule assembly: single agent and combination studies with taxol, epothilone B, and discodermolide.
    Gertsch J; Meier S; Müller M; Altmann KH
    Chembiochem; 2009 Jan; 10(1):166-75. PubMed ID: 19058273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Basis of Microtubule Stabilization by Discodermolide.
    Prota AE; Bargsten K; Redondo-Horcajo M; Smith AB; Yang CH; McDaid HM; Paterson I; Horwitz SB; Fernando Díaz J; Steinmetz MO
    Chembiochem; 2017 May; 18(10):905-909. PubMed ID: 28207984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The microtubule-stabilizing agent discodermolide competitively inhibits the binding of paclitaxel (Taxol) to tubulin polymers, enhances tubulin nucleation reactions more potently than paclitaxel, and inhibits the growth of paclitaxel-resistant cells.
    Kowalski RJ; Giannakakou P; Gunasekera SP; Longley RE; Day BW; Hamel E
    Mol Pharmacol; 1997 Oct; 52(4):613-22. PubMed ID: 9380024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simplified discodermolide analogues: synthesis and biological evaluation of 4-epi-7-dehydroxy-14,16-didemethyl-(+)-discodermolides as microtubule-stabilizing agents.
    Choy N; Shin Y; Nguyen PQ; Curran DP; Balachandran R; Madiraju C; Day BW
    J Med Chem; 2003 Jul; 46(14):2846-64. PubMed ID: 12825928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total synthesis of the potent microtubule-stabilizing agent (+)-discodermolide.
    Harried SS; Lee CP; Yang G; Lee TI; Myles DC
    J Org Chem; 2003 Aug; 68(17):6646-60. PubMed ID: 12919029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclostreptin binds covalently to microtubule pores and lumenal taxoid binding sites.
    Buey RM; Calvo E; Barasoain I; Pineda O; Edler MC; Matesanz R; Cerezo G; Vanderwal CD; Day BW; Sorensen EJ; López JA; Andreu JM; Hamel E; Díaz JF
    Nat Chem Biol; 2007 Feb; 3(2):117-25. PubMed ID: 17206139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tubulin-bound conformation of discodermolide derived by NMR studies in solution supports a common pharmacophore model for epothilone and discodermolide.
    Sánchez-Pedregal VM; Kubicek K; Meiler J; Lyothier I; Paterson I; Carlomagno T
    Angew Chem Int Ed Engl; 2006 Nov; 45(44):7388-94. PubMed ID: 17036370
    [No Abstract]   [Full Text] [Related]  

  • 13. The discodermolide hairpin structure flows from conformationally stable modular motifs.
    Jogalekar AS; Kriel FH; Shi Q; Cornett B; Cicero D; Snyder JP
    J Med Chem; 2010 Jan; 53(1):155-65. PubMed ID: 19894728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total synthesis of a library of designed hybrids of the microtubule-stabilising anticancer agents taxol, discodermolide and dictyostatin.
    Paterson I; Naylor GJ; Fujita T; Guzmán E; Wright AE
    Chem Commun (Camb); 2010 Jan; 46(2):261-3. PubMed ID: 20024345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quantitative evaluation of the effects of inhibitors of tubulin assembly on polymerization induced by discodermolide, epothilone B, and paclitaxel.
    Dabydeen DA; Florence GJ; Paterson I; Hamel E
    Cancer Chemother Pharmacol; 2004 May; 53(5):397-403. PubMed ID: 15060743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of (+)-discodermolide-paclitaxel hybrids leading to enhanced biological activity.
    Smith AB; Sugasawa K; Atasoylu O; Yang CP; Horwitz SB
    J Med Chem; 2011 Sep; 54(18):6319-27. PubMed ID: 21870795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wild-type class I beta-tubulin sensitizes Taxol-resistant breast adenocarcinoma cells harboring a beta-tubulin mutation.
    Wiesen KM; Xia S; Yang CP; Horwitz SB
    Cancer Lett; 2007 Nov; 257(2):227-35. PubMed ID: 17869412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discodermolide, a cytotoxic marine agent that stabilizes microtubules more potently than taxol.
    ter Haar E; Kowalski RJ; Hamel E; Lin CM; Longley RE; Gunasekera SP; Rosenkranz HS; Day BW
    Biochemistry; 1996 Jan; 35(1):243-50. PubMed ID: 8555181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for the development of novel Taxol-like agents.
    Mooberry SL
    Methods Mol Med; 2007; 137():289-302. PubMed ID: 18085237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discodermolide analogues as the chemical component of combination bacteriolytic therapy.
    Smith AB; Freeze BS; LaMarche MJ; Sager J; Kinzler KW; Vogelstein B
    Bioorg Med Chem Lett; 2005 Aug; 15(15):3623-6. PubMed ID: 15979874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.